Welcome to LookChem.com Sign In|Join Free

CAS

  • or

306935-96-6

Post Buying Request

306935-96-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

306935-96-6 Usage

Description

5-[3-(TRIFLUOROMETHOXY)PHENYL]-2-FURALDEHYDE is a chemical compound with the molecular formula C11H7F3O3. It is an aromatic aldehyde derivative featuring a furan ring and a trifluoromethoxy group attached to a phenyl ring. 5-[3-(TRIFLUOROMETHOXY)PHENYL]-2-FURALDEHYDE is commonly utilized in organic synthesis and pharmaceutical research as a building block for creating various other organic compounds. Additionally, it has been studied for its potential biological activities and can serve as a starting material for the synthesis of potential drug candidates. The presence of the trifluoromethoxy group significantly influences its chemical and physical properties, making it a valuable tool in the development of new pharmaceuticals and other chemical applications.

Uses

Used in Organic Synthesis:
5-[3-(TRIFLUOROMETHOXY)PHENYL]-2-FURALDEHYDE is used as a building block in organic synthesis for the creation of various other organic compounds. Its unique structure and functional groups make it a versatile component in the synthesis of complex organic molecules.
Used in Pharmaceutical Research:
In pharmaceutical research, 5-[3-(TRIFLUOROMETHOXY)PHENYL]-2-FURALDEHYDE is used as a starting material for the synthesis of potential drug candidates. Its potential biological activities and the impact of the trifluoromethoxy group on its properties make it a promising candidate for the development of new pharmaceuticals.
Used in Chemical Applications:
5-[3-(TRIFLUOROMETHOXY)PHENYL]-2-FURALDEHYDE is also used in various chemical applications due to the significant influence of the trifluoromethoxy group on its chemical and physical properties. This makes it a valuable tool in the development of new chemical products and technologies.

Check Digit Verification of cas no

The CAS Registry Mumber 306935-96-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,6,9,3 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 306935-96:
(8*3)+(7*0)+(6*6)+(5*9)+(4*3)+(3*5)+(2*9)+(1*6)=156
156 % 10 = 6
So 306935-96-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H7F3O3/c13-12(14,15)18-9-3-1-2-8(6-9)11-5-4-10(7-16)17-11/h1-7H

306935-96-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-[3-(trifluoromethoxy)phenyl]furan-2-carbaldehyde

1.2 Other means of identification

Product number -
Other names 5-[3-(Trifluoromethoxy)phenyl]-2-furaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:306935-96-6 SDS

306935-96-6Downstream Products

306935-96-6Relevant articles and documents

Inhibitors of HCV NS5B polymerase. Part 1: Evaluation of the southern region of (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid

Pfefferkorn, Jeffrey A.,Greene, Meredith L.,Nugent, Richard A.,Gross, Rebecca J.,Mitchell, Mark A.,Finzel, Barry C.,Harris, Melissa S.,Wells, Peter A.,Shelly, John A.,Anstadt, Robert A.,Kilkuskie, Robert E.,Kopta, Laurice A.,Schwende, Francis J.

, p. 2481 - 2486 (2007/10/03)

A novel series of nonnucleoside HCV NS5B polymerase inhibitors were prepared from (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid, a high throughput screening lead. SAR studies combined with structure based drug design focusing on the southern heterobiaryl region of the template led to the synthesis of several potent and orally bioavailable lead compounds. X-ray crystallography studies were also performed to understand the interaction of these inhibitors with HCV NS5B polymerase.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 306935-96-6